Showing results (1-10 of 155) with videos related to
Sort By:
Pageof 16
Vaccine|September 1, 1993
A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangreneE D Williamson, R W TitballCurrent Drug Targets. Infectious Disorders|October 8, 2003
Vaccine development for potential bioterrorism agentsR W Titball, E D WilliamsonBritish Medical Bulletin|August 15, 2002
Vaccines against dangerous pathogensE D Williamson, R W TitballFEMS Microbiology Letters|June 1, 1993
Biochemical and immunological properties of the C-terminal domain of the alpha-toxin of Clostridium perfringensR W Titball, A M Fearn, E D WilliamsonInfection and Immunity|August 26, 1998
The pH 6 antigen of Yersinia pestis binds to beta1-linked galactosyl residues in glycosphingolipidsD Payne, D Tatham, E D Williamson, et al.Microbiology (Reading, England)|July 1, 1996
An aroA mutant of Yersinia pestis is attenuated in guinea-pigs, but virulent in miceP C Oyston, P Russell, E D Williamson, et al.Infection and Immunity|May 1, 1997
Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plagueR W Titball, A M Howells, P C Oyston, et al.Infection and Immunity|November 14, 1997
Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunizationJ Hill, S E Leary, K F Griffin, et al.Microbial Pathogenesis|September 1, 1997
Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plagueS E Leary, K F Griffin, H S Garmory, et al.Pageof 16